NM_006383.4:c.543-172A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006383.4(CIB2):c.543-172A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.253 in 1,493,778 control chromosomes in the GnomAD database, including 49,425 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 3871 hom., cov: 32)
Exomes 𝑓: 0.26 ( 45554 hom. )
Consequence
CIB2
NM_006383.4 intron
NM_006383.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.771
Publications
4 publications found
Genes affected
CIB2 (HGNC:24579): (calcium and integrin binding family member 2) The protein encoded by this gene is similar to that of KIP/CIB, calcineurin B, and calmodulin. The encoded protein is a calcium-binding regulatory protein that interacts with DNA-dependent protein kinase catalytic subunits (DNA-PKcs), and it is involved in photoreceptor cell maintenance. Mutations in this gene cause deafness, autosomal recessive, 48 (DFNB48), and also Usher syndrome 1J (USH1J). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
CIB2 Gene-Disease associations (from GenCC):
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Usher syndrome type 1JInheritance: Unknown, AR Classification: DEFINITIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive nonsyndromic hearing loss 48Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Usher syndrome type 1Inheritance: AR Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 15-78105504-T-C is Benign according to our data. Variant chr15-78105504-T-C is described in ClinVar as Benign. ClinVar VariationId is 1245883.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.265 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.211 AC: 31981AN: 151926Hom.: 3876 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
31981
AN:
151926
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.257 AC: 345243AN: 1341734Hom.: 45554 Cov.: 34 AF XY: 0.256 AC XY: 168138AN XY: 656852 show subpopulations
GnomAD4 exome
AF:
AC:
345243
AN:
1341734
Hom.:
Cov.:
34
AF XY:
AC XY:
168138
AN XY:
656852
show subpopulations
African (AFR)
AF:
AC:
2480
AN:
30254
American (AMR)
AF:
AC:
6073
AN:
29624
Ashkenazi Jewish (ASJ)
AF:
AC:
6321
AN:
21336
East Asian (EAS)
AF:
AC:
6482
AN:
35408
South Asian (SAS)
AF:
AC:
13555
AN:
70574
European-Finnish (FIN)
AF:
AC:
13255
AN:
39056
Middle Eastern (MID)
AF:
AC:
962
AN:
3820
European-Non Finnish (NFE)
AF:
AC:
282232
AN:
1056102
Other (OTH)
AF:
AC:
13883
AN:
55560
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
14320
28641
42961
57282
71602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
9572
19144
28716
38288
47860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.210 AC: 31972AN: 152044Hom.: 3871 Cov.: 32 AF XY: 0.213 AC XY: 15848AN XY: 74308 show subpopulations
GnomAD4 genome
AF:
AC:
31972
AN:
152044
Hom.:
Cov.:
32
AF XY:
AC XY:
15848
AN XY:
74308
show subpopulations
African (AFR)
AF:
AC:
3606
AN:
41498
American (AMR)
AF:
AC:
3045
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
1058
AN:
3468
East Asian (EAS)
AF:
AC:
877
AN:
5156
South Asian (SAS)
AF:
AC:
861
AN:
4822
European-Finnish (FIN)
AF:
AC:
3602
AN:
10586
Middle Eastern (MID)
AF:
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18206
AN:
67922
Other (OTH)
AF:
AC:
473
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1265
2531
3796
5062
6327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
576
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.